Pretransplant test-dose pharmacokinetic profiles: Cyclosporine microemulsion versus corn oil-based soft gel capsule formulation

Journal of the American Society of Nephrology

Volumn 9, Issue 2, 1998, Pages 297-304

  Chueh, Shih Chieh ^a   Kahan, Barry D ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORN OIL; CYCLOSPORIN; CYCLOSPORIN A;

ACCURACY; ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CAPSULE; DRUG CLEARANCE; DRUG FORMULATION; FEMALE; FLUORESCENCE POLARIZATION IMMUNOASSAY; GEL; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MICROEMULSION; ORAL DRUG ADMINISTRATION; PREDICTION; PRIORITY JOURNAL;

EID: 0031913604     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Kahan BD, Reid M, Newburger J: Pharmacokinetics of cyclosporine in human renal transplantation. Transplant Proc 15: 446-453, 1983
2. Calne RY, White DJ, Thiru S, Evans DB, McMaster P, Dunn DC: Cyclosporin A in patients receiving renal allografts from cadaver donors. Lancet 2: 1323-1327, 1978
3. Kahan BD, Grevel J: Overview: Optimization of cyclosporine therapy in renal transplantation by a pharmacokinetic strategy. Transplantation 46: 631-644, 1988
4. Ptachcinski RJ, Venkataramanan R, Burckart GJ: Clinical pharmacokinetics of cyclosporin. Clin Pharmacokinet 11: 107-132, 1986
5. Kahan BD: Cyclosporine. N Engl J Med 321: 1725-1738, 1989
6. Savoldi S, Kahan BD: Relationship of cyclosporine pharmacokinetic parameters to clinical events in human renal transplantation. Transplant Proc 18: 120-128, 1986
7. Lindholm A, Kahan BD: Influence of cyclosporine pharmacokinetics, trough concentrations, and AUC monitoring on outcome after kidney transplantation. Clin Pharmacol Ther 54: 205-218, 1993
8. Greenblatt DJ: Predicting steady state serum concentrations in drugs. Annu Rev Pharmacol Ther 19: 347-356, 1979
9. Kovarik JM, Mueller EA, van Bree JB, Tetzloff W, Kutz K: Reduced inter- and intraindividual variability in cyclosporine pharmacokinetics from a microemulsion formulation. J Pharm Sci 83: 444-446, 1994
10. Kahan BD, Dunn J, Fitts C, Van Buren D, Wombolt D, Pollak R: Reduced inter- and intrasubject variability in cyclosporine pharmacokinetics in renal transplant recipients treated with a microemulsion formulation in conjunction with fasting, low fat or high fat meals. Transplantation 59: 505-511, 1995
11. Kahan BD, Welsh M, Rutzky LP: Challenges in cyclosporine therapy: The role of therapeutic drug monitoring by area under the curve monitoring. Ther Drug Monit 17: 621-624, 1995
12. Amante AJ, Kahan BD: Abbreviated AUC strategy for monitoring cyclosporine microemulsion therapy in the immediate posttransplant period. Transplant Proc 28: 2162-2163, 1996
13. Kahan BD, Welsh M, Rutzky L, Lewis R, Knight R. Katz S: The ability of pretransplant test-dose pharmacokinetic profiles to reduce early adverse events after renal transplantation. Transplantation 53: 345-351, 1992
14. Mueller EA, Kovarik JM, van Bree JB, Tetzloff W, Grevel J, Kutz K: Improved dose linearity of cyclosporine pharmacokinetics from a microemulsion formulation. Pharm Res 11: 301-304, 1994
15. Norusis MJ: SPSS for Windows, Advanced Statistics, User's Guide, Release 6.0, Chicago, SPSS Inc., 1993
16. Keown PA, for the Canadian and International Neoral Study Groups: Use of cyclosporine microemulsion in de novo and stable renal transplantation: Clinical impact, pharmacokinetic consequences and economic benefits. Transplant Proc 28: 2147-2150, 1996
17. Freeman D, Grant D, Levy G, Rochon J, Wong PY, Altraif I, Asfar S: Pharmacokinetics of a new oral formulation of cyclosporine in liver transplant recipients. Ther Drug Monit 17: 213-216, 1995
18. Holt DW, Mueller EA, Kovarik JM, van Bree JB, Richard F, Kutz K: Sandimmun neoral pharmacokinetics: Impact of the new oral formulation. Transplant Proc 27: 1434-1437, 1995
19. Hemming AW, Greig PD, Cattral MS, Chung SW, Lilly LB, Aljumah AA: A microemulsion of cyclosporine without intravenous cyclosporine in liver transplantation. Transplantation 62: 1798-1802, 1996
20. Amante AJ, Meier-Kriesche HU, Schoenberg L, Kahan BD: A pharmacokinetic comparison of corn oil versus microemulsion gelcap formulation of cyclosporine used de novo after renal transplantation. Transplant Int 10: 217-222, 1997
21. Cooney GF, Michaelis H, Alisa B, Shaw LM, LiBetti G: Utility of pretransplantation cyclosporine pharmacokinetic studies. Ther Drug Monit 16: 151-154, 1994
22. Katz SM, Amante AJ, Schoenberg L, Kahan BD: Oral cyclosporine preparations immediately following renal transplantation. Transplant Proc 28: 2164, 1996
23. Kahan BD: Case study: De novo application of Neoral in renal transplantation. Transplant Proc 28: 2189-2192, 1996
24. Lodge JPA, Pollard SG, for the UK Neoral Study Group: Neoral vs Sandimmun: Interim results of a randomized trial of efficacy and safety in preventing acute rejection in new renal transplant recipients. Transplant Proc 29: 272-273, 1997